According to Natco Pharma 's latest financial reports the company's current EPS (TTM) is 0,50 โฌ. In 2022 the company made an earnings per share (EPS) of 0,24 โฌ an increase over its 2021 EPS that were of 0,18 โฌ.
Year | EPS | Change |
---|---|---|
2023 (TTM) | 0,51 โฌ | 109.93% |
2022 | 0,24 โฌ | 31.27% |
2021 | 0,18 โฌ | -43.11% |
2020 | 0,32 โฌ | -7.23% |
2019 | 0,35 โฌ | -41.42% |
2018 | 0,59 โฌ | 28.54% |
2017 | 0,46 โฌ | 58.87% |
2016 | 0,29 โฌ | 130.83% |
2015 | 0,13 โฌ | 34.13% |
2014 | 0,09406 โฌ | 9.4% |
2013 | 0,08598 โฌ | 8.42% |
2012 | 0,07930 โฌ |